TH98396A - 4- [4 - ({[4- chloro-3- (trifluoromethyl) phenyl] carbamoyl} amino) -3-fluorophenoxy] -N-methyl pyridine-2-carboxamide monohydrate - Google Patents
4- [4 - ({[4- chloro-3- (trifluoromethyl) phenyl] carbamoyl} amino) -3-fluorophenoxy] -N-methyl pyridine-2-carboxamide monohydrateInfo
- Publication number
- TH98396A TH98396A TH701005024A TH0701005024A TH98396A TH 98396 A TH98396 A TH 98396A TH 701005024 A TH701005024 A TH 701005024A TH 0701005024 A TH0701005024 A TH 0701005024A TH 98396 A TH98396 A TH 98396A
- Authority
- TH
- Thailand
- Prior art keywords
- carbamoyl
- trifluoromethyl
- chloro
- phenyl
- amino
- Prior art date
Links
- ZOPOQLDXFHBOIH-UHFFFAOYSA-N regorafenib hydrate Chemical compound O.C1=NC(C(=O)NC)=CC(OC=2C=C(F)C(NC(=O)NC=3C=C(C(Cl)=CC=3)C(F)(F)F)=CC=2)=C1 ZOPOQLDXFHBOIH-UHFFFAOYSA-N 0.000 title 1
- 239000000470 constituent Substances 0.000 claims abstract 4
- 238000000034 method Methods 0.000 claims abstract 4
- -1 {[4- chloro -3- (trifluoromethyl) phenyl] -carbamoyl} amino Chemical group 0.000 claims abstract 4
- 229950004696 Flusalan Drugs 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 abstract 1
Abstract
DC60 (29/12/51) การประดิษฐ์นี้จะเกี่ยวข้องกับ 4-[4-({[4-คลอโร-3-(ไตรฟลูออโรเมทธิล)ฟีนิล]- คาร์บาโมอิล} อะมิโน)-3-ฟลูออโรฟีนนอกซี]-N-เมทธิลไพริดีน-2-คาร์บอกซาไมด์ โมโนไฮเดรท, เกี่ยวข้องกับกระบวนการสำหรับการเตรียมของสิ่งนี้, เกี่ยวข้องกับองค์ประกอบทางเภสัชกรรม ซึ่งประกอบด้วยสิ่งนี้ และเกี่ยวข้องกับการใช้ของสิ่งนี้ในการควบคุมความผิดปกติ กรประดิษฐ์นี้จะเกี่ยวข้องกับ 4[4-({[4-คลอโร-3-(ไตรฟลูออโรเมทธิล)ฟีนิล]- คาร์บาโมอิล}อะมิโน)-3-ฟลูออโรฟีนนอกซี]-N-เมทธิลไพริดีน-2-คาร์บอกซไมด์ โมโนไฮเดรท, เกี่ยวข้องกับกระบวนการสำหรับกราเตรียมของสิ่งนี้, เกี่ยวข้องกับองค์ประกอบทางเภสัชกรรม ซึ่งประกอบด้วยสิ่งนี้ และเกี่ยวข้องกับการใช้ของสิ่งนี้ในการควบคุมความผิดปกติ สิทธิบัตรยา DC60 (29/12/51). This invention relates to 4- (4 - ({[4- chloro -3- (trifluoromethyl) phenyl] -carbamoyl} amino) -3- fluorophene outside C] -N-methyl pyridine-2-carboxamide monohydrate, involved in the process for the preparation of this, involved the pharmaceutical constituents. Which consists of this And involves the use of this to control malfunctions. This invention is related to 4 (4 - ({[4- chloro-3- (trifluoromethyl) phenyl] -carbamoyl} amino) -3- fluorophenoxide ] -N-methyl pyridine-2-carboxamide monohydrate, involved in the process for the preparation of this, involved the pharmaceutical constituents. Which consists of this And involves the use of it in the control of drug patent disorders
Claims (1)
Publications (2)
Publication Number | Publication Date |
---|---|
TH98396A true TH98396A (en) | 2009-09-24 |
TH98396B TH98396B (en) | 2009-09-24 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1114637T1 (en) | 4- [4 - ({[4-CHLORO-3- (trifluoromethyl) phenyl)] carbamoyl} amino) -3-fluorophenoxy] -N-methylpyridine-2-carboxide | |
LTC1793824I2 (en) | New pharmaceutical compositions comprising 4- (4- (3- (4-chloro-3-trifluoromethylphenyl) ureido) -3-fluorophenoxy) pyridine-2-carboxylic acid for the treatment of hyperproliferative disorders | |
BRPI0515946A (en) | tosylate salt, its preparation and use, as well as pharmaceutical composition comprising the same | |
EA200700387A1 (en) | HYDRATES AND POLYMORPHES 4 - [[(7R) -8-CYCLOPENTYL-7-ETHYL-5,6,7,8-TETRAHYDRO-5-METHYL-6-OXO-2-PTERIDINYL] AMINO] -3-METHOXY-N- (1-METHYL-4-PIPERIDINYL) BENZAMIDE, METHODS OF THEIR PRODUCTION AND THEIR APPLICATION AS A MEDICINE | |
TH98396A (en) | 4- [4 - ({[4- chloro-3- (trifluoromethyl) phenyl] carbamoyl} amino) -3-fluorophenoxy] -N-methyl pyridine-2-carboxamide monohydrate | |
TH98396B (en) | 4- (4 - ({[4-C chloro-3- (trifluoromethyl) phenyl] carbamoyl} amino) -3- fluorophenoxy ] -N-methyl pyridine-2-carboxamide monohydrate | |
TH92464A (en) | compound | |
TH81375A (en) | New compound | |
TH76106A (en) | New alkine compounds with antagonistic MCH Activitants and medicines containing these compounds | |
TH145968A (en) | New compounds and elements And methods of use | |
TH92800A (en) | New compound | |
TH96578A (en) | Pyrolotriacine kinase inhibitors | |
TH87500A (en) | A new connection between agomelatin and thymus regulators and pharmaceutical mixtures with this. | |
TH106988A (en) | Oxasolo Pirimidine is an Edg-1 receptor agonist. | |
TH81542A (en) | Uses of compounds for the treatment of disease | |
TH100489A (en) | Crystalline form | |
DOP2005000184A (en) | THERMODYNAMICALLY STABLE FORM OF A TOSILATE SALT | |
TH88496A (en) | Chemical compound | |
TH101958A (en) | Aspartic protease inhibitors | |
TH104292A (en) | The composition of the medicinal product containing lactate and calcium and the use of them | |
TH97648A (en) | Amine derivatives | |
TH84733A (en) | New compound | |
TH84282B (en) | Heterocyclic as nicotinic acid receptor agonist for the treatment of dyslipidemia. | |
TH96551A (en) | Pyridinil and Pyrimidinil derivatives have been replaced for metabolic modifications and therapeutic approaches for related disorders. | |
TH98274A (en) | Control substances cannabinoid receptor |